[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BiotechNewswire](/creator/twitter/BiotechNewswire)
"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX @EUdaiichisankyo"  
[X Link](https://x.com/BiotechNewswire/status/1981208966035333345) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T04:00Z 4342 followers, XX engagements


"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX"  
[X Link](https://x.com/BiotechNewswire/status/1981314666698592332) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T11:00Z 4342 followers, XX engagements


"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology"  
[X Link](https://x.com/BiotechNewswire/status/1981375065519174123) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T15:00Z 4342 followers, XX engagements